NL-OMON54017
招募中
2 期
DEBuT-LRP study: Intravascular Identification and Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques - DEBuT-LRP
概览
- 阶段
- 2 期
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Academisch Medisch Centrum
- 入组人数
- 50
- 状态
- 招募中
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\. Patient has an acute coronary syndrome without ST\-segment elevation on the
- •ECG (NSTE\-ACS), includingnon\-ST\-elevation myocardial infarction and unstable
- •angina pectoris.
- •2\. An invasive revascularization strategy for NSTE\-ACS with PCI is chosen.
排除标准
- •Angiographic exclusion criteria:
- •1\. Previous coronary artery bypass\-grafting;
- •2\. A chronic total occlusion is present;
- •3\. Too many (complex) coronary lesions requiring staged PCI procedure(s);
- •4\. Procedural complication of the index PCI;
- •Clinical exclusion criteria:
- •5\. Unstable patients (the presence of cardiogenic shock, need for intubation,
- •need for inotropes);
- •6\. Patients with ST\-segment elevations on the ECG requiring immediate primary
- •7\. Body weight \> 250 kg;
结局指标
主要结局
未指定
相似试验
撤回
2 期
DEBuT-LRP study: Non-invasive and Intravascular Identification and Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaquesmyocardial infarction10011082NL-OMON49521Academisch Medisch Centrum40
招募中
1 期
Intradermal LPS to study vascular responsesImmunological/cardiovascular conditionsTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]CTIS2024-512377-27-00Centre for Human Drug Research32
进行中（未招募）
不适用
Evaluation study of the peripheral infusion leakage in infants and children: ivWatchpost surgical childrenJPRN-jRCTs062210017Kanazawa Tomoyuki100
招募中
不适用
The study of biomarkers for intractable vascular anomalies and associated with pharmacological action of sirolimusVascular anomaliesJPRN-UMIN000029173Gifu University50
进行中（未招募）
1 期
Clinical trial of a single dose of treprostinil injected as a depot under the skin to investigate the effect on the digital blood flow and safety in patients with Raynaud’s Phenomenon due to Systemic SclerosisRaynaud’s phenomenon secondary to systemic sclerosisMedDRA version: 20.0Level: PTClassification code 10037912Term: Raynaud's phenomenonSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2019-002444-24-GBCamurus AB12